BioCryst Pharmaceuticals ... (BCRX)
NASDAQ: BCRX
· Real-Time Price · USD
8.37
-0.08 (-0.95%)
At close: Aug 15, 2025, 3:59 PM
8.37
0.06%
After-hours: Aug 15, 2025, 07:46 PM EDT
BioCryst Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 88.53M | 105.19M | 104.71M | 96.84M | 78.41M | 84.33M | 110.64M | 150.91M | 146.22M | 155.14M | 304.77M | 246.9M | 272.57M | 395.5M | 504.39M | 199.6M | 210.31M | 226.9M |
Short-Term Investments | 172M | 189.9M | 216.14M | 233.17M | 193.62M | 252.22M | 278.34M | 246.69M | 267.9M | 243.02M | 119.54M | 179.96M | 144.91M | 47.96M | 3.21M | n/a | 8.11M | 13.45M |
Long-Term Investments | 11.5M | 20.55M | 20.32M | 19.43M | 64.32M | n/a | n/a | n/a | 3.44M | 3.43M | 18.08M | 34.33M | n/a | n/a | 6.83M | n/a | n/a | n/a |
Other Long-Term Assets | 27.22M | 29.95M | 28.34M | 21.63M | 24.52M | 12.96M | 80K | 79K | 6.95M | 7.05M | -33.5M | -49.59M | -15.69M | n/a | 6.47M | n/a | n/a | n/a |
Receivables | 91.18M | 93.39M | 79.07M | 72.46M | 68.76M | 60.59M | 56.95M | 53.65M | 57.67M | 48.64M | 50.6M | 42.61M | 41.49M | 36.41M | 29.41M | 26.21M | 27.62M | 18.39M |
Inventory | 5.04M | 6.87M | 8.09M | 7.56M | 4.45M | 29.78M | 28.68M | 29.63M | 27.03M | 27.47M | 27.53M | 27.02M | 23.38M | 16.14M | 15.79M | 13.66M | 9.85M | 5.11M |
Other Current Assets | 41.71M | 14.62M | 13.96M | 16.28M | 1.79M | 1.8M | 1.8M | 1.58M | 1.57M | 1.46M | 1.47M | 1.44M | 1.45M | 3.35M | 3.35M | 4.3M | 4.35M | 4.01M |
Total Current Assets | 398.46M | 409.03M | 421.97M | 427.13M | 363.46M | 447.1M | 495.97M | 502.47M | 414.12M | 490.88M | 516.5M | 509M | 494.85M | 511.71M | 566.14M | 252.74M | 265.8M | 273.77M |
Property-Plant & Equipment | 20M | 19.57M | 19.79M | 23.07M | 19.85M | 7.83M | 20.91M | 20.38M | 8.44M | 8.38M | 15.42M | 15.26M | 15.69M | 16.01M | 8.71M | 13.02M | 11.48M | 10.66M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 58.73M | 70.07M | 68.45M | 64.13M | 108.96M | 20.79M | 20.99M | 20.46M | 18.83M | 18.85M | 33.5M | 49.59M | 15.69M | 16.01M | 22.02M | 13.02M | 11.48M | 10.66M |
Total Assets | 457.19M | 480.05M | 490.42M | 491.25M | 472.42M | 467.89M | 516.96M | 522.92M | 529.88M | 509.74M | 550M | 558.59M | 510.54M | 527.72M | 588.15M | 265.76M | 277.28M | 284.43M |
Account Payables | 8.59M | 10.05M | 11.64M | 13.48M | 7.79M | 11.91M | 20.89M | 10.57M | 13.89M | 6.25M | 14.36M | 8.62M | 12.02M | 13.88M | 27.81M | 19.69M | 10.09M | 13.53M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | 79.25M | n/a | 522K | 1.78M | 1.2M | 1.22M | 1.55M | 1.52M | 1.47M | 1.42M | 602K | 551K | 405K |
Short-Term Debt | 37.75M | 2.87M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 30M | 30M | 30M |
Other Current Liabilities | 130.82M | n/a | 145.97M | 33M | n/a | n/a | 23.57M | n/a | n/a | n/a | 65.44M | n/a | n/a | n/a | 52M | n/a | n/a | n/a |
Total Current Liabilities | 177.16M | 139.85M | 160.38M | 153.57M | 129.06M | 119.92M | 149.99M | 90.76M | 93.5M | 85.16M | 105.51M | 81.64M | 95.39M | 81.02M | 103.72M | 133.61M | 115.6M | 101.2M |
Long-Term Debt | 690.64M | 782.03M | 795.92M | 796.11M | 808.48M | 813.04M | 811.26M | 833.18M | 819.3M | 746.93M | 733.28M | 713.65M | 144.52M | 604.46M | 585.46M | 132.05M | 126.8M | 123.04M |
Other Long-Term Liabilities | 454K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 477.67M | n/a | n/a | 142.11M | 136.86M | 131.3M |
Total Long-Term Liabilities | 701.62M | 792.12M | 805.97M | 806.25M | 818.96M | 824.14M | 822.5M | 843.15M | 5.8M | 5.93M | 739.08M | 719.62M | 628.38M | 610.92M | 591.42M | 279.2M | 267.76M | 258.22M |
Total Liabilities | 878.78M | 931.97M | 966.35M | 959.82M | 948.02M | 944.06M | 972.49M | 933.91M | 918.6M | 838.02M | 844.6M | 801.25M | 723.77M | 691.93M | 695.14M | 412.81M | 383.36M | 359.42M |
Total Debt | 738.92M | 794.99M | 808.74M | 809.14M | 850.64M | 826.88M | 848.71M | 845.43M | 5.8M | 5.93M | 741.45M | 721.81M | 152.85M | 613M | 593.24M | 168.54M | 161.88M | 157.92M |
Common Stock | 2.1M | 2.09M | 2.08M | 2.07M | 2.07M | 2.06M | 2.06M | 1.9M | 1.9M | 1.89M | 1.88M | 1.86M | 1.86M | 1.86M | 1.84M | 1.8M | 1.79M | 1.78M |
Retained Earnings | -1.76B | -1.77B | -1.77B | -1.74B | -1.73B | -1.72B | -1.68B | -1.62B | -1.58B | -1.51B | -1.45B | -1.38B | -1.34B | -1.28B | -1.21B | -1.19B | -1.13B | -1.09B |
Comprehensive Income | 1.65M | 1.13M | 921K | 2.29M | 557K | 771K | 1.34M | 800K | 690K | 585K | 26K | -98K | 15K | 186K | 177K | 114K | 87K | 182K |
Shareholders Equity | -421.59M | -451.93M | -475.93M | -468.56M | -475.61M | -476.17M | -455.53M | -410.99M | -1.58B | -1.51B | -1.45B | -1.38B | -1.34B | -1.28B | -106.99M | -147.04M | -106.08M | -74.99M |
Total Investments | 183.51M | 210.45M | 236.46M | 252.6M | 257.93M | 252.22M | 278.34M | 246.69M | 3.44M | 3.43M | 137.62M | 214.29M | 144.91M | 47.96M | 10.04M | n/a | 8.11M | 13.45M |